Contrast-Induced Nephropathy Prevention in Angiography

Understanding the Risk Stratification

Severe renal failure is defined as creatinine clearance <30 mL/min, which represents the highest risk category for both contrast-induced nephropathy and bleeding complications with anticoagulants used during angiography, according to the European Heart Journal 1, 3
Moderate renal impairment (creatinine clearance 30-60 mL/min or estimated glomerular filtration rate 20-59 mL/min) requires heightened precautions but does not contraindicate angiography, as recommended by the American College of Cardiology 2
Serum creatinine >2.0 mg/dL has been identified as an independent risk factor for cardiac complications after procedures, as reported in Circulation 4, 5
For patients >70 years old, preoperative creatinine >2.6 mg/dL places them at much greater risk for requiring chronic dialysis postoperatively, although this applies more to cardiac surgery than diagnostic angiography, according to Circulation 5

Administer 250-500 mL of sodium chloride 0.9% before and after the procedure to reduce contrast-induced nephropathy risk, as recommended by the European Heart Journal 1, 3
Limit contrast medium to a maximum of 50 mL for diagnostic procedures in patients with renal dysfunction, as suggested by the European Heart Journal 1, 3
Use either isosmolar contrast medium or low-molecular-weight contrast medium other than ioxaglate or iohexol in patients with chronic kidney disease, according to the American College of Cardiology 2
Assess creatinine level up to day 3 after contrast injection to detect contrast-induced nephropathy, as recommended by the European Heart Journal 1

Enoxaparin is contraindicated or requires dose adjustment when creatinine clearance <30 mL/min, as recommended by the European Heart Journal 1, 3
Fondaparinux is technically contraindicated in severe renal failure but may have a lower bleeding risk than enoxaparin, according to the European Heart Journal 1, 3
Bivalirudin requires a reduced infusion rate if creatinine clearance <30 mL/min, as suggested by the European Heart Journal 1, 3
Eptifibatide and tirofiban require dose adjustments in patients with renal dysfunction, as recommended by the European Heart Journal 1, 3

Do not rely solely on serum creatinine to assess renal function, and always calculate glomerular filtration rate using the Cockcroft-Gault equation or MDRD equation, as recommended by the European Heart Journal and the American College of Cardiology 1, 2
Do not withhold necessary angiography solely based on renal function, as even patients with severe renal dysfunction can undergo angiography when clinically indicated, provided appropriate preventive measures are implemented, according to the European Heart Journal and the American College of Cardiology 1, 2
Do not forget to assess for additional contrast-induced nephropathy risk factors beyond renal function, including older age, diabetes mellitus, dehydration, and use of nephrotoxic medications, as recommended by the European Heart Journal 1, 3
Do not use high-osmolar contrast agents, and always use low-osmolar or iso-osmolar contrast media in patients with any degree of renal impairment, as suggested by the European Heart Journal 1, 3